Ciara C OSullivan
Overview
Explore the profile of Ciara C OSullivan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
690
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gergelis K, Huston A, OSullivan C, Laack N, Corbin K
Hematol Oncol Clin North Am
. 2025 Jan;
39(2):359-375.
PMID: 39827041
Addressing various dimensions of well-being can help improve oncology patients' symptoms and their overall quality of life (QOL); similar strategies can be used to support caregivers of oncology patients to...
2.
Jahan N, Taraba J, Boddicker N, Giridhar K, Leon-Ferre R, Tevaarwerk A, et al.
Clin Breast Cancer
. 2024 Nov;
PMID: 39516069
Purpose: This study evaluates real-world outcomes, toxicities, and prescribing patterns of PARP inhibitors (PARPis) for the treatment of metastatic breast cancer (MBC). Patients And Methods: Electronic health records of 62...
3.
OSullivan C, Higgins A, Alkurashi A, Ahluwalia V, Taraba J, McKie P, et al.
Front Oncol
. 2024 Nov;
14:1434492.
PMID: 39497716
Background: The advent of antibody-drug conjugates (ADCs) represents a landmark advance in cancer therapy, permitting targeted delivery of a potent cytotoxic agent to tumor cells with minimal damage to surrounding...
4.
Tang X, Prodduturi N, Thompson K, Weinshilboum R, OSullivan C, Boughey J, et al.
Nucleic Acids Res
. 2024 Oct;
52(21):e99.
PMID: 39445795
The OmicsFootPrint framework addresses the need for advanced multi-omics data analysis methodologies by transforming data into intuitive two-dimensional circular images and facilitating the interpretation of complex diseases. Utilizing deep neural...
5.
OSullivan C, Larson N, Vierkant R, Smith M, Chauhan C, Couch F, et al.
Arch Public Health
. 2024 Aug;
82(1):119.
PMID: 39113124
Purpose: The aims of the Advocate-BREAST project are to study and improve the breast cancer (BC) patient experience through education and patient-centered research. Methods: In December 2021, an electronic REDCap...
6.
OSullivan C, Vierkant R, Larson N, Smith M, Chauhan C, Couch F, et al.
Cancers (Basel)
. 2024 Jul;
16(14).
PMID: 39061134
Background: There are limited evidence-based data to guide treatment recommendations for breast cancer (BC) patients ≥80 years (P80+). Identifying and addressing unmet needs are critical. Aims: Advocate-BREAST80+ compared the needs...
7.
Weiss A, Mitchell M, OSullivan C, Boughey J
Ann Surg Oncol
. 2024 Jul;
31(11):7372-7374.
PMID: 39037526
No abstract available.
8.
Weiss A, Colugnati F, Mitchell M, Li Y, Marin C, Gergelis K, et al.
Ann Surg Oncol
. 2024 Jul;
31(11):7362-7371.
PMID: 38976157
Background: Axillary lymph node dissection (ALND) is increasingly omitted for breast cancer patients with pathologic nodal disease after neoadjuvant chemotherapy (NAC). This study aimed to understand when and why surgeons...
9.
Haddad T, Suman V, Giridhar K, Sideras K, Northfelt D, Ernst B, et al.
Clin Cancer Res
. 2024 May;
30(15):3147-3156.
PMID: 38752717
Purpose: We previously reported that postmenopausal women with estrogen receptor-α-positive breast cancer receiving adjuvant anastrozole 1 mg/day (ANA1) with estrone (E1) ≥1.3 pg/mL and estradiol (E2) ≥0.5 pg/mL [inadequate estrogen...
10.
Tang X, Prodduturi N, Thompson K, Weinshilboum R, OSullivan C, Boughey J, et al.
bioRxiv
. 2024 Apr;
PMID: 38585820
The OmicsFootPrint framework addresses the need for advanced multi-omics data analysis methodologies by transforming data into intuitive two-dimensional circular images and facilitating the interpretation of complex diseases. Utilizing Deep Neural...